A PhysioMechanical Model of Esophageal Function in Eosinophilic Esophagitis.
Dysphagia
Motility
Peristalsis
Stricture
Journal
Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
14
03
2023
revised:
01
05
2023
accepted:
05
05
2023
pmc-release:
01
09
2024
medline:
22
8
2023
pubmed:
2
6
2023
entrez:
1
6
2023
Statut:
ppublish
Résumé
Eosinophilic esophagitis (EoE) is characterized by eosinophilic inflammation, but also heterogeneous presentations involving fibrostenotic esophageal remodeling and esophageal dysmotility. We aimed to define and evaluate phenotypes of EoE using functional lumen imaging probe (FLIP) panometry (ie, a PhysioMechanical classification of EoE). Patients with EoE who completed FLIP during endoscopy were included in a cross-sectional study. FLIP studies were analyzed for distensibility plateau and compliance of the esophageal body, maximum esophagogastric junction diameter, and contractile response pattern. These FLIP features were then applied to define PhysioMechanical classifications. A total of 215 patients with EoE (mean [standard deviation] age 38 [12] years; 31% female) were included. Seven PhysioMechanical classifications were identified that differed by various clinical characteristics, including symptom duration (P < .001) and Endoscopic EoE Reference Scores (EREFS) (P < .001). In particular, patients with "nonreactive fibrostenosis" (n = 14), had greater symptom duration (median [interquartile range] 20 [10-30] years) and more frequently had EREFS grade 2 or 3 ring scores (14 of 14 patients) than patients with a "normal" PhysioMechanical classification (symptom duration: 3 [1-8] years; 4 of 50 [8%] had EREFS grade 2 or 3 rings). In addition, among patients off treatment at cross-sectional evaluation (n = 46), there was a difference between PhysioMechanical classifications in future proton pump inhibitor (PPI) response rates (ie, achieving peak mucosal eosinophil count <15 per high-powered field after PPI treatment); P = .009. PPI response ranged from 87% (13 of 15 patients) with "isolated esophagogastric junction outflow obstruction" to 11% (1 of 9 patients) with "spastic-reactive fibrostenosis." Classifying PhysioMechanical esophageal function in EoE based on FLIP panometry features may facilitate defining disease severity and directing management in EoE.
Sections du résumé
BACKGROUND & AIMS
Eosinophilic esophagitis (EoE) is characterized by eosinophilic inflammation, but also heterogeneous presentations involving fibrostenotic esophageal remodeling and esophageal dysmotility. We aimed to define and evaluate phenotypes of EoE using functional lumen imaging probe (FLIP) panometry (ie, a PhysioMechanical classification of EoE).
METHODS
Patients with EoE who completed FLIP during endoscopy were included in a cross-sectional study. FLIP studies were analyzed for distensibility plateau and compliance of the esophageal body, maximum esophagogastric junction diameter, and contractile response pattern. These FLIP features were then applied to define PhysioMechanical classifications.
RESULTS
A total of 215 patients with EoE (mean [standard deviation] age 38 [12] years; 31% female) were included. Seven PhysioMechanical classifications were identified that differed by various clinical characteristics, including symptom duration (P < .001) and Endoscopic EoE Reference Scores (EREFS) (P < .001). In particular, patients with "nonreactive fibrostenosis" (n = 14), had greater symptom duration (median [interquartile range] 20 [10-30] years) and more frequently had EREFS grade 2 or 3 ring scores (14 of 14 patients) than patients with a "normal" PhysioMechanical classification (symptom duration: 3 [1-8] years; 4 of 50 [8%] had EREFS grade 2 or 3 rings). In addition, among patients off treatment at cross-sectional evaluation (n = 46), there was a difference between PhysioMechanical classifications in future proton pump inhibitor (PPI) response rates (ie, achieving peak mucosal eosinophil count <15 per high-powered field after PPI treatment); P = .009. PPI response ranged from 87% (13 of 15 patients) with "isolated esophagogastric junction outflow obstruction" to 11% (1 of 9 patients) with "spastic-reactive fibrostenosis."
CONCLUSIONS
Classifying PhysioMechanical esophageal function in EoE based on FLIP panometry features may facilitate defining disease severity and directing management in EoE.
Identifiants
pubmed: 37263308
pii: S0016-5085(23)00804-1
doi: 10.1053/j.gastro.2023.05.031
pmc: PMC10527622
mid: NIHMS1905535
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
552-563.e4Subventions
Organisme : NIDDK NIH HHS
ID : P01 DK117824
Pays : United States
Informations de copyright
Copyright © 2023 AGA Institute. Published by Elsevier Inc. All rights reserved.
Références
Neurogastroenterol Motil. 2016 Dec;28(12):1854-1860
pubmed: 27380834
Neurogastroenterol Motil. 2022 Jan;34(1):e14192
pubmed: 34120383
Allergy. 2012 Apr;67(4):477-90
pubmed: 22313241
Neurogastroenterol Motil. 2011 Mar;23(3):208-14, e111
pubmed: 21091849
Gastroenterology. 2013 Dec;145(6):1230-6.e1-2
pubmed: 23954315
Gastroenterology. 2011 Jan;140(1):82-90
pubmed: 20858491
Gut. 2013 Apr;62(4):489-95
pubmed: 22619364
Am J Gastroenterol. 2018 Nov;113(11):1594-1599
pubmed: 30315308
Am J Gastroenterol. 2021 Dec 1;116(12):2357-2366
pubmed: 34668487
Gastrointest Endosc. 2016 Jun;83(6):1142-8
pubmed: 26608127
Am J Gastroenterol. 2013 May;108(5):679-92; quiz 693
pubmed: 23567357
Gastroenterology. 2020 May;158(6):1776-1786
pubmed: 32359562
Gastroenterology. 2021 Oct;161(4):1133-1144
pubmed: 34153298
Pediatr Allergy Immunol. 2017 Jun;28(4):312-319
pubmed: 28339136
Clin Gastroenterol Hepatol. 2021 Aug;19(8):1554-1563
pubmed: 32763482
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1719-1728.e3
pubmed: 34768010
Gastroenterology. 2014 Dec;147(6):1255-66.e21
pubmed: 25160980
J Clin Gastroenterol. 2016 Feb;50(2):134-40
pubmed: 25710524
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1101-1107.e1
pubmed: 23591279
Clin Gastroenterol Hepatol. 2019 Mar;17(4):674-681.e1
pubmed: 30081222
Am J Gastroenterol. 2018 Jun;113(6):836-844
pubmed: 29700481
Gastrointest Endosc. 2014 Apr;79(4):577-85.e4
pubmed: 24275329
Neurogastroenterol Motil. 2023 Apr;35(4):e14525
pubmed: 36600494